For the quarter ended September 2023, Nextgen Healthcare reported revenue of $176.42 million, up 10.7% over the same period last year. EPS came in at $0.31, compared to $0.25 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $176.08 million, representing a surprise of +0.20%. The company delivered an EPS surprise of +24.00%, with the consensus EPS estimate being $0.25.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Nextgen Healthcare performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenues- Software, hardware, and other non-recurring: $15.10 million compared to the $15.05 million average estimate based on three analysts. The reported number represents a change of -5.3% year over year.
- Revenues- Recurring: $161.32 million versus $161.68 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +12.4% change.
- Revenues- Recurring- Managed services: $35.06 million versus the two-analyst average estimate of $35 million. The reported number represents a year-over-year change of +12.9%.
- Revenues- Software, hardware, and other non-recurring- Software license and hardware: $5.52 million versus the two-analyst average estimate of $6.37 million. The reported number represents a year-over-year change of -30.3%.
- Revenues- Software, hardware, and other non-recurring- Other non-recurring services: $9.58 million versus $8.41 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +19.4% change.
- Revenues- Recurring- Support and maintenance: $37.56 million versus $38.68 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -1.5% change.
- Revenues- Recurring- Subscription services: $50.26 million versus $51.36 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +15.8% change.
- Revenues- Recurring- Transactional and data services: $38.43 million versus the two-analyst average estimate of $36.40 million. The reported number represents a year-over-year change of +24.4%.
View all Key Company Metrics for Nextgen Healthcare here>>>Shares of Nextgen Healthcare have returned +0.9% over the past month versus the Zacks S&P 500 composite's -2.3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Image: Bigstock
Here's What Key Metrics Tell Us About Nextgen Healthcare (NXGN) Q2 Earnings
For the quarter ended September 2023, Nextgen Healthcare reported revenue of $176.42 million, up 10.7% over the same period last year. EPS came in at $0.31, compared to $0.25 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $176.08 million, representing a surprise of +0.20%. The company delivered an EPS surprise of +24.00%, with the consensus EPS estimate being $0.25.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Nextgen Healthcare performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenues- Software, hardware, and other non-recurring: $15.10 million compared to the $15.05 million average estimate based on three analysts. The reported number represents a change of -5.3% year over year.
- Revenues- Recurring: $161.32 million versus $161.68 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +12.4% change.
- Revenues- Recurring- Managed services: $35.06 million versus the two-analyst average estimate of $35 million. The reported number represents a year-over-year change of +12.9%.
- Revenues- Software, hardware, and other non-recurring- Software license and hardware: $5.52 million versus the two-analyst average estimate of $6.37 million. The reported number represents a year-over-year change of -30.3%.
- Revenues- Software, hardware, and other non-recurring- Other non-recurring services: $9.58 million versus $8.41 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +19.4% change.
- Revenues- Recurring- Support and maintenance: $37.56 million versus $38.68 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -1.5% change.
- Revenues- Recurring- Subscription services: $50.26 million versus $51.36 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +15.8% change.
- Revenues- Recurring- Transactional and data services: $38.43 million versus the two-analyst average estimate of $36.40 million. The reported number represents a year-over-year change of +24.4%.
View all Key Company Metrics for Nextgen Healthcare here>>>Shares of Nextgen Healthcare have returned +0.9% over the past month versus the Zacks S&P 500 composite's -2.3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.